Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Cardiovascular Morbidity in Arterial Claudication
NCT02387450Phase 3Unknown
- Sponsor
- Centre Hospitalier Universitaire d'Angers
- Start
- Sep 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sildenafil in Peripheral Arterial Disease (PAD), sponsored by Centre Hospitalier Universitaire d'Angers. Status: unknown.
02
Drugs
sildenafil
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT02387450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02387450.